Kenneth Horton
General Counsel bei SENSEONICS HOLDINGS, INC.
Vermögen: 813 924 $ am 30.04.2024
Profil
Kenneth L.
Horton is currently the General Counsel at Senseonics Holdings, Inc. He previously served as the Chairman at Lumira Capital (USA) Corp.
From 2012 to 2015, he was the Chief Legal Officer & Executive Vice President at Vertex Pharmaceuticals, Inc. Kenneth also held the position of VP-Acquisitions, Ventures & General Counsel at Revvity, Inc. Prior to that, he was the EVP-Corporate Development & General Counsel at Nordion (Canada), Inc. from 2005 to 2012.
Mr. Horton completed his undergraduate studies at Dartmouth College and obtained his graduate degree from Harvard Law School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.04.2024 | 1 947 186 ( 0,37% ) | 813 924 $ | 30.04.2024 |
Aktive Positionen von Kenneth Horton
| Unternehmen | Position | Beginn |
|---|---|---|
| SENSEONICS HOLDINGS, INC. | General Counsel | 01.10.2017 |
Ehemalige bekannte Positionen von Kenneth Horton
| Unternehmen | Position | Ende |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 20.01.2015 |
| NORDION INC | General Counsel | 01.01.2012 |
| Lumira Capital (USA) Corp. | Vorsitzender | - |
| REVVITY, INC. | Corporate Officer/Principal | - |
Ausbildung von Kenneth Horton
| Dartmouth College | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| REVVITY, INC. | Health Technology |
| SENSEONICS HOLDINGS, INC. | Electronic Technology |
| Private Unternehmen | 2 |
|---|---|
Nordion (Canada), Inc.
 Nordion (Canada), Inc. Pharmaceuticals: MajorHealth Technology Nordion (Canada), Inc. provides drug discovery and development research services. It specializes in health science, gamma irradiation, radiopharmaceutical, gamma sterilization, medical isotopes, and production irradiators. The company was founded in 1946 and is headquartered in Ottawa, Canada. | Health Technology |
| Lumira Capital (USA) Corp. |
